Escape from stress granule sequestration: another way to drug resistance?
Authors:
Open Access
- 24 November 2010
- journal article
- research article
- Published by Portland Press Ltd. in Biochemical Society Transactions
- Vol. 38 (6) , 1537-1542
Abstract
Overexpression of P-glycoprotein, encoded by the MDR1 (multidrug resistance 1) gene, is often responsible for multidrug resistance and chemotherapy failure in cancer. We have demonstrated that, in leukaemic cells, P-glycoprotein expression is regulated at the translational level. More recently, we have shown that in cells overexpressing P-glycoprotein, MDR1 mRNA does not aggregate into translationally silent stress granules. Importantly, this is not unique for MDR1, since other transcripts encoding transmembrane proteins, and which are thus translated at the endoplasmic reticulum, follow the same pattern. By using a series of chimaeric transcripts, we have demonstrated that transcript localization at the endoplasmic reticulum bypasses the signals dictating stress granule sequestration. Polysome profile analyses and protein synthesis experiments indicate that, upon stress withdrawal, endoplasmic-reticulum-bound transcripts resume translation faster than those at the cytosol, which have been sequestered into stress granules. This may represent a novel mechanism by which drug-resistant cells respond quickly to stress, helping them to survive the cytotoxic effect of chemotherapeutic drugs.Keywords
This publication has 45 references indexed in Scilit:
- Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug BindingScience, 2009
- Resistance to chemotherapy: new treatments and novel insights into an old problemBritish Journal of Cancer, 2008
- Modulation of multidrug resistance efflux pump activity to overcome chemoresistance in cancerCurrent Opinion in Pharmacology, 2006
- Targeting multidrug resistance in cancerNature Reviews Drug Discovery, 2006
- The molecular basis of multidrug resistance in cancer: The early years of P‐glycoprotein researchFEBS Letters, 2005
- Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defenseToxicology and Applied Pharmacology, 2005
- Reproducible measurements of AML blast p-glycoprotein function in 2 center analysesBlood, 2005
- Phase II Study of ET-743 in Advanced Soft Tissue Sarcomas: A European Organisation for the Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group TrialJournal of Clinical Oncology, 2005
- Ecteinascidin 743, a transcription-targeted chemotherapeutic that inhibits MDR1 activationProceedings of the National Academy of Sciences, 2000
- Increased P-glycoprotein messenger RNA stability in rat liver tumors in vivoJournal of Cellular Physiology, 1998